Stay updated on Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Sign up to get notified when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.

Latest updates to the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check20 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical trial for newly diagnosed multiple myeloma and the addition of new trial details, such as the GMMG HD7 study and its randomization structure. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference22%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 24, 2025.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and an earlier date of January 24, 2025.SummaryDifference0.2%
- Check71 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check86 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
Stay in the know with updates to Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.